哈门那(HUM)
搜索文档
Humana Stock Getting Closer to 52-Week Lows: A Buying Opportunity?
ZACKS· 2024-10-08 01:56
Shares of Humana Inc. (HUM) have dropped 30.2% over the past month to close at $240.03 on Friday. The steep declines last week have pushed the stock's price closer to the lower end of its 52-week range of $213.31-$530.54. Having underperformed its peers like Molina Healthcare, Inc. (MOH) and Centene Corporation (CNC) , the overall industry, and the S&P 500, the company's current share price seems an excellent opportunity to build a position in a renowned HMO company. After all, you would much rather buy clo ...
Occidental and Humana Are on the Casualty List
Gurufocus· 2024-10-07 23:23
文章核心观点 - 作者认为在市场下跌时买入优质股票是一个明智的投资策略 [1] - 作者列举了4只在第三季度遭受重创但有望强劲反弹的股票 [1] 行业和公司总结 石油行业 - 油价从每桶83美元下跌到69美元,导致多只油气股大跌,其中包括Occidental Petroleum(OXY)下跌18% [2] - 作者认为油气将在2030年代前仍是美国主要能源来源,同时中东局势也可能影响全球油价 [2] 医疗保险行业 - Humana是美国最大的医疗保险公司之一,主要为Medicare、Medicaid和Tricare提供保险服务 [3] - Humana的保险计划在政府评估中遭遇低评级,可能会影响未来的客户增长,股价在第三季度下跌15% [3] - 尽管遭遇挫折,但Humana过去10年收入增长接近12%,作者认为管理层有能力扭转局面 [3] 半导体行业 - Amkor Technology是一家从事半导体测试和封装的公司,主要客户包括苹果和高通 [4] - 过去一年Amkor的销售和利润分别下降约8%和34%,导致股价在第三季度下跌23% [4] - 但分析师中有6家给予Amkor"买入"评级 [4] 汽车零部件行业 - Visteon是一家为多家汽车制造商提供仪表和电子零件的供应商 [4] - 受到利率上升和汽车销售下滑的影响,Visteon第三季度股价下跌11% [5] - 但随着美联储降息,作者预计汽车销售有望回升 [5]
NYSE: HUM Lawsuit against Directors filed - Investors in shares of Humana Inc. (NYSE: HUM) should contact the Shareholders Foundation
Prnewswire· 2024-10-04 05:14
SAN DIEGO, Oct. 3, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a lawsuit was filed by aNYSE: HUM investor against certain directors of Humana Inc. Investors who purchased shares of Humana Inc. (NYSE: HUM) prior to August 2022 and continue to hold any of thoseNYSE: HUM shares have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. In June 2024 an investor inNYSE: HUM shares filed a lawsuit over alleged securities laws viol ...
Johnson Fistel Begins Investigation into Humana, Inc. Following a Significant Drop in the Company's Stock
GlobeNewswire News Room· 2024-10-03 21:30
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Humana Inc. (NYSE: HUM) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. What if I purchased Humana securities? If you purchased securities and suffered losses on your in ...
Humana Inc. Investors: Company Investigated by the Portnoy Law Firm
GlobeNewswire News Room· 2024-10-03 07:31
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Humana Inc. ("Humana" or "the Company") (NYSE: HUM) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Humana investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorney Lesley F. P ...
Stock Of The Day: Will Humana Remember?
Benzinga· 2024-10-03 02:43
The best traders don't play offense. They play defense. When they trade, they are reactionary. They let the market tell them what to do. These traders know that the market has a "memory." This means that important support and resistance levels can stay intact for long periods of time. It could be weeks, months — or even years. As you can see on the chart, this could be the case with the $225 level for Humana Inc. HUM. This is why our team of technical analysis experts has made it our Stock of the Day. If a ...
Humana Inc (HUM) Trading Down 17.63% on Oct 2
Gurufocus· 2024-10-03 00:05
Shares of Humana Inc (HUM, Financial) fell 17.63% in mid-day trading on Oct 2. The stock reached an intraday low of $213.31, before recovering slightly to $230.18, down from its previous close of $279.45. This places HUM 56.61% below its 52-week high of $530.54 and 7.91% above its 52-week low of $213.31. Trading volume was 11,224,614 shares, 847.6% of the average daily volume of 1,324,273. Wall Street Analysts Forecast Based on the one-year price targets offered by 21 analysts, the average target price for ...
Humana and Interwell Health Expand Value-Based Support to Florida
ZACKS· 2024-09-26 00:46
Humana Inc. (HUM) recently announced the expansion of its value-based care agreement to include eligible Medicare Advantage members in Florida. Humana and Interwell Health will provide value-based support services for eligible members suffering from chronic kidney disease (CKD) and end-stage kidney disease (ESKD). The services are available in 14 and 39 states for members with CKD and ESKD, respectively. This move bodes well for Humana as it will enhance the quality of care and improve health outcomes for p ...
Humana: A Beaten-Down Health Care Stock to Re-Emerge as Inflation Fades
Gurufocus· 2024-09-24 21:00
Humana Inc. (HUM, Financial) has suffered from a sharp sell-off this year, losing a quarter of its market capitalization. The stock should be able to recover in 2025 as headwinds fade and investors realize the company's fundamentals are unchanged, if not strengthened. Humana is one of the largest health insurance providers in the U.S., along with UnitedHealth Group Inc. (UNH, Financial), CVS Health Corp. (CVS, Financial) and Elevance Health Inc. (ELV, Financial). The company's business model is concentrated ...
Humana's Falling Share Price Gives Investors An Opportunity
Seeking Alpha· 2024-09-18 10:37
Health insurance and health services provider, Humana (NYSE: HUM ), the country's second largest Medical Advantage insurer, has slid 10% in the last week. The slide is on the back of the company announcing that it is exiting 13 markets, triggering investor fears An economics graduate with a passion for financial history; I apply my knowledge to markets in an effort to hopelessly predict trends and spot value. All opinions are my own and should not be taken seriously. Analyst's Disclosure: I/we have no stock ...